GERNA
BIOTECH

Genome-Editing RNAs
The next generation genome editing technology

Get in touch

OFFICE LINE

+82 053-0000-0000

EMAIL

INFO@GERNABIO.COM

WORKING HOURS

09:00-18:00 (UTC+9)

OFFICE LINE

1.800.555.6789

EMERGENCY

1.800.555.0000

WORKING HOURS

9:00am – 6:00pm

ABOUT US

The GERNA Biotech had developed the next generation genome editing technology, RIDE. The RIDE (RNA-Instructed DNA Editing) technology is a new way to gene mending including point mutation, multiple variants and deletion mutation. The RIDE used long guide RNAs, not use Cas system. It make benefit of safety of gene therapies. 

Long guide RNA

The RIDE used guide RNA with long length (approx. 35 mer). The RIDE has less off-target error than existing technique of gene therapies, such as CRISPR-Cas system. The gene therapies will be more safety with the long reads.

Read More

Pushing the limits of CAS

The RIDE is the next generation genome editing technology. The RIDE mending the genetic mutation without CAS system. It is mean that the RIDE have not double-strand break issue and PAM sequence dependency.
Read More

New Things

The RIDE technology will create a new era for genetics and gene therapies. GERNA Biotech had confirmed successfully gene mending with human genome which has been known the causes of the genetic disease. 

Read More

We provided the way to gene mending without the Cas.

Get in touch

The pipelines

We try to make pipelines for a new era for human.

READ MORE

TESTIMONIALS

Office Assistant

Lee DaGeon

Ph.D in Life Science.
Bioinformatician

Founder & CEO

Dr. Song Kitae

MSc. Biology
Researcher

MSc. Seo Ga young

OFFICE LINE

1.800.555.6789

EMERGENCY

1.800.555.0000

WORKING HOURS

9:00am – 6:00pm